P1‐287: Proton spectroscopy in Alzheimer's disease: A longitudinal multiple time point study

Jonathan M. Schott(UK Dementia Research Institute), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), Martin N. Rossor(National Hospital for Neurology and Neurosurgery), Adam Waldman(Royal Society of Edinburgh), Chris Frost(Eli Lilly (United States)), David MacManus(NIHR Queen Square Dementia Biomedical Research Unit)
Alzheimer s & Dementia
July 1, 2008
10.1016/j.jalz.2008.05.877
Cited by 0

Related Papers

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
|Nature Genetics|2019|3.3k